|
Image-Guided High-Intensity Interstitial Ultrasound for Thermal Ablation of Uteri
|
1R41CA121740-01A2
|
$149,948
|
DIEDERICH, CHRIS
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
RTOG Tissue Bank
|
5U24CA114734-04
|
$793,026
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Genetic Susceptibility to Endometrial Cancer
|
5R01CA082838-09
|
$325,450
|
DEVIVO, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Telomere Length and Endometrial Cancer
|
5R03CA132190-02
|
$87,500
|
DEVIVO, Immaculata
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multidisciplinary Training in Image-Guided Therapy
|
2R25CA089017-06A2
|
$538,479
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Hormonal modulation of latent endometrial precancers
|
5R01CA100833-05
|
$257,238
|
MUTTER, GEORGE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-25
|
$855,703
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
AACR-TREC-NIH Think Tank Conference: Energy Balance and Cancer; Mechanisms and Me
|
1R13CA134016-01
|
$10,000
|
Berger, Nathan
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-22
|
$1,042,698
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
CALIFORNIA TEACHERS STUDY
|
7R01CA077398-11
|
$2,482,687
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
UMB/DFHCC Comprehensive Cancer Partnership Program
|
5U56CA118641-04
|
$404,798
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
Inflamation and the Risk of Endometrial Cancer
|
5K07CA117979-03
|
$134,490
|
Viswanathan, Akila
|
DANA-FARBER CANCER INSTITUTE
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-23
|
$1,053,633
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
EORTC DATA CENTER
|
5U10CA011488-38
|
$793,241
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Community Clinical Oncology Program
|
2U10CA035199-25
|
$484,645
|
GRINBLATT, DAVID
|
EVANSTON NORTHWESTERN HEALTHCARE
|
|
PTEN and the molecular genetics of endometrial cancer
|
2R01CA097097-05A1
|
$344,347
|
DI CRISTOFANO, ANTONIO
|
FOX CHASE CANCER CENTER
|
|
Fox Chase Cancer Center CCOP-Research Base Program
|
3U10CA101178-03S2
|
$624,917
|
ENGSTROM, PAUL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-46S1
|
$113,159
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-46S2
|
$171,963
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-46
|
$8,028,491
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
SBIR PHASE 1 TOPIC 237: GYLCAN ARRAYS FOR BIOMARKER DISCOVERY AND VALIDATION
|
N43CN700063-000
|
|
HURTADO-ZIOLA, NANCY
|
GCFREE, INC
|
|
Molecular MR Imaging by Targeting Cancer Markers
|
5R21CA127190-02
|
$144,500
|
LIU, ZHI-REN
|
GEORGIA STATE UNIVERSITY
|
|
Gynecologic Oncology Group
|
3U10CA027469-28S1
|
|
DISAIA, PHILIP
|
GYNECOLOGIC ONCOLOGY GROUP
|
|
Gynecologic Oncology Group
|
3U10CA027469-28S2
|
$31,718
|
DISAIA, PHILIP
|
GYNECOLOGIC ONCOLOGY GROUP
|
|
Gynecologic Oncology Group
|
3U10CA027469-28S3
|
$76,391
|
DISAIA, PHILIP
|
GYNECOLOGIC ONCOLOGY GROUP
|
|
Gynecologic Oncology Group
|
5U10CA027469-28
|
$8,690,028
|
DISAIA, PHILIP
|
GYNECOLOGIC ONCOLOGY GROUP
|
|
GYNECOLOGIC ONCOLOGY GROUP
|
5U10CA101165-05
|
$3,906,708
|
DiSaia, Philip
|
GYNECOLOGIC ONCOLOGY GROUP
|
|
Gynecologic Oncology Group- HUMAN SPECIMEN BANK
|
5U24CA114793-04
|
$524,259
|
DISAIA, PHILIP
|
GYNECOLOGIC ONCOLOGY GROUP
|
|
Molecular basis of uterine cellular interactions
|
5R01CA112686-14
|
$230,408
|
Sassoon, David
|
INSTITUT NATIONAL DE LA RECHERCHE SCIENT
|
|
Kansas City Clinical Oncology Program CCOP
|
5U10CA035176-25
|
$630,725
|
Gaur, Rakesh
|
KANSAS CITY CLINICAL ONCOLOGY PROGRAM
|
|
Marshfield Community Clinical Oncology Program
|
2U10CA035412-25
|
$946,378
|
Weiss, Matthias
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
Minority Based Community Clinical Oncology Program at Meharry Medical College
|
3U10CA107612-05S1
|
$86,725
|
Wolff, Steven
|
MEHARRY MEDICAL COLLEGE
|
|
Minority Based Community Clinical Oncology Program at Meharry Medical College
|
5U10CA107612-05
|
$390,738
|
Wolff, Steven
|
MEHARRY MEDICAL COLLEGE
|
|
Missouri Valley Cancer Consortium CCOP
|
5U10CA063849-15
|
$891,324
|
Soori, Gamini
|
MISSOURI VALLEY CANCER CONSORTIUM, INC.
|
|
Research Management and Support
|
RMS2008
|
$336,082,664
|
N/A
|
National Cancer Institute
|
|
Sweden and Denmark linked registries on hospital discharges and subsequent cancer
|
Z01 CP010183-00560
|
$4,450
|
Anderson, William
|
DCEG (NCI)
|
|
Breast, ovarian and endometrial cancer in Polish women
|
Z01 CP010126-01033
|
$2,147,797
|
Brinton, Louise
|
DCEG (NCI)
|
|
GOG Studies
|
Z01 CP010126-01068
|
$156,812
|
Brinton, Louise
|
DCEG (NCI)
|
|
Columbia, Missouri serum bank participant extended follow-up
|
Z01 CP010126-01103
|
$116,813
|
Brinton, Louise
|
DCEG (NCI)
|
|
Endometrial cancer epidemiologic study
|
Z01 CP010126-03050
|
$3,071
|
Brinton, Louise
|
DCEG (NCI)
|
|
Endometrial Hyperplasia and Endometrial Cancer Nested Case-Control Study
|
Z01 CP010126-10048
|
$39,534
|
Brinton, Louise
|
DCEG (NCI)
|
|
Pilot: Silent Markers in Endometrial and Ovarian Tissue
|
Z01 CP010126-10302
|
$197,175
|
Brinton, Louise
|
DCEG (NCI)
|
|
FIT - Bone mineral density and subsequent cancer risk
|
Z01 CP010128-01063
|
$1,705
|
Brinton, Louise
|
DCEG (NCI)
|
|
Infertility follow-up study: 1965-88
|
Z01 CP010128-01082
|
$36,214
|
Brinton, Louise
|
DCEG (NCI)
|
|
BCDDF: Breast cancer detection demonstration project followup study - I
|
Z01 CP010182-01030
|
$439,832
|
Gail, Mitchell
|
DCEG (NCI)
|
|
In vivo Imaging Analysis of Steroid/Nuclear Receptor Function
|
Z01 BC 010308
|
$239,690
|
Hager, Gordon
|
CCR (NCI)
|
|
Continuation of follow-up of DES-exposed cohorts
|
Z01 CP010168-00020
|
$747,750
|
Hoover, Robert
|
DCEG (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|